4.8 Article

Extracellular Traps Increase Burden of Bleeding by Damaging Endothelial Cell in Acute Promyelocytic Leukaemia

Journal

FRONTIERS IN IMMUNOLOGY
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2022.841445

Keywords

extracellular traps; endothelial cell; acute promyelocytic leukaemia; bleeding; platelets

Categories

Ask authors/readers for more resources

This study investigates the role of ETs in endothelial injury in APL and suggests that targeting ETs production may be an effective approach for relieving vascular leakage and reducing the burden of bleeding.
The rate of complete remission of acute promyelocytic leukemia (APL) is currently over 90% because of the use of all-trans retinoic acid (ATRA) with arsenic trioxide (ATO). However, hemorrhagic mortality has emerged as the most significant barrier to APL-induced remission. Neutrophils extracellular traps (NETs/ETs) cause vascular leakage by damaging the integrity of endothelial cells. We have previously demonstrated that APL cells treated with ATRA/ATO undergo a cell death process, releasing extracellular chromatin, termed ETosis/NETosis. However, the mechanism underlying the involvement of ETs in endothelial injury in APL remain largely unknown. Here, we analysed the ability of mature and immature neutrophils to release ETs, and their interaction with platelets (PLTs) in APL. Importantly, the effect of ETs on vascular endothelium in APL was discussed. Our results showed that the ability of immature neutrophils to release ETs was impaired in APL, whereas mature neutrophils produced ETs, which were associated with activated PLTs. Moreover, ATRA+ATO induced immature neutrophil differentiation, as well as increased the release of ETs from mature neutrophils. The excessive ETs damaged endothelial cells, causing blood cell leakage. Removing ETs using DNase 1 alleviated endothelial damage and improved blood cells leakage. Our results indicate that vascular endothelial injury is at least partially associated with ETs in APL, and that targeting ETs production may be an effective approach for relieving vascular leakage and reducing the burden of bleeding in APL.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Dentistry, Oral Surgery & Medicine

Microvesicles, blood cells, and endothelial cells mediate phosphatidylserine-related prothrombotic state in patients with periodontitis

Nan Zuo, Wenhui Liu, Tenglong Hu, Yingmiao Liu, Baorong Li, Huan Liu, Haijiao Jing, Xiaojing Chen, Yueyue Li, Jingwen Du, Tianshui Hu, Zengxiang Dong, Yumei Niu, Jialan Shi

Summary: The prothrombotic state in patients with periodontitis is mediated by PS+ cells and microvesicles stimulated by elevated levels of inflammatory cytokines. PS exposure on blood cells and endothelial cells significantly decreased after inhibiting the effect of inflammatory cytokines. Non-surgical periodontal therapy significantly attenuated the release of microvesicles and the PS exposure of blood cells in severe periodontitis.

JOURNAL OF PERIODONTOLOGY (2022)

Article Cell Biology

Thrombosis and hemorrhage in myeloproliferative neoplasms: The platelet perspective

Yiming Feng, Yue Zhang, Jialan Shi

Summary: Classical myeloproliferative neoplasm (MPN) is a clonal disease characterized by abnormal expansion of hematopoietic stem cells. MPN patients are more susceptible to thrombotic events, but antiplatelet therapies may cause bleeding. Platelets play a critical role in the pathogenesis of MPN and optimizing antithrombotic treatment strategies by adjusting the administration of antiplatelet drugs may achieve simultaneous control of thrombosis and bleeding.

PLATELETS (2022)

Review Cell Biology

Circulating Microparticles in the Pathogenesis and Early Anticoagulation of Thrombosis in COVID-19 With Kidney Injury

Chengyue Wang, Chengyuan Yu, Valerie A. Novakovic, Rujuan Xie, Jialan Shi

Summary: As more is learned about the pathophysiological mechanisms of COVID-19, systemic thrombosis has been recognized as being associated with more severe clinical manifestations, mortality and sequelae. Microparticles (MPs) are membrane bubbles released in response to activation, injury or apoptosis of cells, and can be used as a risk factor to predict renal microthrombosis and kidney injury. Early prophylactic anticoagulant therapy reduces mortality and improves clinical outcomes.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Cell Biology

The Central Role of Extracellular Vesicles in the Mechanisms of Thrombosis in COVID-19 Patients With Cancer and Therapeutic Strategies

Haijiao Jing, Nan Zuo, Valerie A. Novakovic, Jialan Shi

Summary: Cancer patients are more susceptible to SARS-CoV-2 and may develop severe COVID-19 infections. Approximately 20% of COVID-19 patients with cancer experience venous thrombosis. Thrombus formation is associated with severe clinical manifestations, mortality, and sequelae. This review focuses on the pathophysiological mechanisms of thrombosis in COVID-19 patients with cancer and proposes an antithrombotic strategy.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Immunology

Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation

Chengyue Wang, Chengyuan Yu, Haijiao Jing, Xiaoming Wu, Valerie A. Novakovic, Rujuan Xie, Jialan Shi

Summary: Many discharged COVID-19 patients with sequelae suffer from reduced quality of life, which places a burden on the healthcare system, families, and society. The pathophysiological mechanisms of long COVID involve persistent viral replication, chronic hypoxia, and inflammation. Thrombosis plays a crucial role in the impairment of various organ functions. Currently, there is no effective treatment for long COVID. However, there is growing evidence that early anticoagulation therapy can improve outcomes by reducing thrombotic sequelae.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Hematology

Membrane curvature and PS localize coagulation proteins to filopodia and retraction fibers of endothelial cells

Christopher Carman, Dessislava N. Nikova, Yumiko Sakurai, Jialan Shi, Valerie A. Novakovic, Jan T. Rasmussen, Wilbur A. Lam, Gary E. Gilbert

Summary: Prior reports have indicated that convex membrane curvature of phosphatidylserine (PS)-containing vesicles enhances the formation of binding sites for factor Va and lactadherin, but the relationship between convex curvature and protein localization on cells remains unknown. In this study, a membrane topology model was developed to explore this relationship further. Results show that the ridges of membranes with maximal curvature selectively bound lactadherin and factor Va, supporting the assembly of prothrombinase complexes.

BLOOD ADVANCES (2023)

Review Cardiac & Cardiovascular Systems

The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment

Langjiao Liu, Haijiao Jing, Xiaoming Wu, Mengqi Xiang, Valerie A. Novakovic, Shuye Wang, Jialan Shi

Summary: This article describes the pathophysiological mechanism by which SARS-CoV-2 induces lung and heart complications through injury of endothelial cells, emphasizing the procoagulant effect of microparticles (MPs) and phosphatidylserine (PS), and demonstrates the importance of early antithrombotic therapy.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Review Immunology

The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors

Mengqi Xiang, Xiaoming Wu, Haijiao Jing, Langjiao Liu, Chunxu Wang, Yufeng Wang, Valerie A. A. Novakovic, Jialan Shi

Summary: Patients with COVID-19 often experience hypoxemia, impaired lung function, and abnormal imaging manifestations. Platelet activation and abnormalities contribute to increased pulmonary permeability, gas exchange disorders, and an increased risk of thrombotic events. Phosphatidylserine (PS) plays a significant role in thrombus formation. Antiplatelet therapy and targeting PS may be potential treatment strategies for COVID-19 hypercoagulability and thrombosis.

FRONTIERS IN IMMUNOLOGY (2022)

Editorial Material Infectious Diseases

Early antithrombotic therapy for another highly lethal viral pneumonia pandemic

Xiaoming Wu, Mengqi Xiang, Haijiao Jing, Langjiao Liu, Chunli Wang, Valerie A. Novakovic, Jialan Shi

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Review Immunology

Pathophysiological mechanisms of thrombosis in acute and long COVID-19

Haijiao Jing, Xiaoming Wu, Mengqi Xiang, Langjiao Liu, Valerie A. Novakovic, Jialan Shi

Summary: This review investigates the crosstalk between inflammation and thrombosis in COVID-19 patients, focusing on the contributions of inflammation to thrombosis pathogenesis and proposing combined use of anti-inflammatory and anticoagulant therapies.

FRONTIERS IN IMMUNOLOGY (2022)

Review Peripheral Vascular Disease

Damage to endothelial barriers and its contribution to long COVID

Xiaoming Wu, Mengqi Xiang, Haijiao Jing, Chengyue Wang, Valerie A. Novakovic, Jialan Shi

Summary: The emergence of viral variants has resulted in the ongoing global battle against COVID-19, while a subset of convalescent individuals continues to experience persistent and prolonged sequelae known as long COVID. Various studies demonstrate endothelial injury in acute COVID-19 and convalescent patients, highlighting its central role in the progression of COVID-19 and development of long COVID. Different organs possess different types of endothelia with specific features, forming distinct endothelial barriers and executing diverse physiological functions. Endothelial injury leads to increased permeability, glycocalyx shedding, extension of phosphatidylserine-rich filopods, and barrier damage. This article primarily focuses on these endothelial barriers and their contribution to long COVID.

ANGIOGENESIS (2023)

Article Gastroenterology & Hepatology

Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma

Subodh Kumar, Jiangning Zhao, Srikanth Talluri, Leutz Buon, Shida Mu, Lakshmi B. Potluri, Chengcheng Liao, Jialan Shi, Chandraditya Chakraborty, Gabriel B. Gonzalez, Yu-Tzu Tai, Jaymin Patel, Jagannath Pal, Hiroshi Mashimo, Mehmet K. Samur, Nikhil C. Munshi, Masood A. Shammas

Summary: This study identified APE1 as a driver of genomic evolution in esophageal adeno-carcinoma and other solid tumors. APE1 suppression caused cell cycle arrest, impaired growth, and increased cell toxicity, while APE1 overexpression led to massive chromosomal instability and oncogenic transformation. Inhibitors targeting APE1 have the potential to treat EAC and other cancers by regulating genomic instability.

GASTROENTEROLOGY (2023)

Review Oncology

Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis

Haijiao Jing, Xiaoming Wu, Mengqi Xiang, Chengyue Wang, Valerie A. Novakovic, Jialan Shi

Summary: Tumor progression and metastasis are associated with the release of microparticles (MPs) that contain phosphatidylserine (PS) and nucleic acids. Coagulation factors and platelets play important roles in promoting tumor development, angiogenesis, and metastasis. Anticoagulation therapy targeting the phosphatidylserine-mediated coagulation cascade can slow tumor progression and improve patient treatment. Development of therapies targeting platelet activation and platelet-tumor cell interactions may also impede tumor growth and spread.

CANCERS (2023)

Review Cardiac & Cardiovascular Systems

The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury

Mengqi Xiang, Xiaoming Wu, Haijiao Jing, Valerie A. Novakovic, Jialan Shi

Summary: The role of hypoxia, vascular endothelial injury, and thrombotic inflammation in worsening COVID-19 symptoms has been widely recognized. Obesity is an independent risk factor for severe respiratory diseases and can aggravate the acute phase of COVID-19. Early interventions, such as supplemental oxygen and comprehensive antithrombotic therapy, are recommended to reduce ICU admissions, mortality, and sequelae.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Article Oncology

RAD51 Is Implicated in DNA Damage, Chemoresistance and Immune Dysregulation in Solid Tumors

Chengcheng Liao, Srikanth Talluri, Jiangning Zhao, Shidai Mu, Subodh Kumar, Jialan Shi, Leutz Buon, Nikhil C. Munshi, Masood A. Shammas

Summary: This study shows that increased expression of RAD51 is associated with poor prognosis in esophageal, breast, and colon cancer patients. Elevated RAD51 promotes growth and contributes to spontaneous and chemotherapy-induced damage and instability of genetic material in cancer cells. RAD51 inhibitors can prevent the activation of these mechanisms, inhibiting the growth of cancer cells while preserving the integrity of genetic material and the immune system.

CANCERS (2022)

No Data Available